Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.
about
Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertensionOcular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in RabbitsBrinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions.
P2860
Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@en
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@nl
type
label
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@en
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@nl
prefLabel
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@en
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@nl
P2860
P356
P1476
Brinzolamide ophthalmic suspen ...... ucoma and ocular hypertension.
@en
P2093
Michele Iester
P2860
P304
P356
10.2147/OPTH.S3182
P407
P577
2008-09-01T00:00:00Z